High Ki-67 as a biomarker for identifying patients with high-risk early breast cancer treated in monarchE

dc.contributor.authorFasching, P.
dc.contributor.authorHarbeck, N.
dc.contributor.authorJohnston, S.
dc.contributor.authorMartin, M.
dc.contributor.authorToi, M.
dc.contributor.authorRastogi, P.
dc.contributor.authorSong, C.
dc.date.accessioned2025-05-10T19:28:20Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage244
dc.identifier.issn2296-5270
dc.identifier.issn2296-5262
dc.identifier.scopusqualityQ3
dc.identifier.startpage244
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7274
dc.identifier.volume44
dc.identifier.wosWOS:000760622600450
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofOncology Research and Treatment
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleHigh Ki-67 as a biomarker for identifying patients with high-risk early breast cancer treated in monarchE
dc.typeConference Object

Dosyalar